1308669-76-2 Usage
Structure
A derivative of pyridine with a bromine and fluorine atom
Applications
a. Organic synthesis
b. Pharmaceutical research
c. Potential biological activities
d. Building block for pharmaceuticals and agrochemicals
e. Drug discovery and development
f. Reagent in organic chemistry reactions
Unique properties
Valuable tool in drug discovery and development due to its structure and properties
Functional groups
a. Pyridine ring
b. Bromine atom
c. Fluorine atom
d. Ethyl group
e. Carbonyl group (ketones)
Chemical reactivity
Can be used to introduce the pyridine ring into a molecule in organic chemistry reactions
Solubility
Not mentioned in the material, but generally, similar compounds are soluble in organic solvents like ethanol, methanol, or acetone
Stability
Not mentioned in the material, but generally, similar compounds are stable at room temperature and should be stored in a cool, dry place
Safety precautions
Not mentioned in the material, but generally, similar compounds should be handled with care due to potential toxicity or reactivity with other chemicals
Purity
Not mentioned in the material, but generally, the purity of a compound is important for its effectiveness and safety in various applications
Check Digit Verification of cas no
The CAS Registry Mumber 1308669-76-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,0,8,6,6 and 9 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1308669-76:
(9*1)+(8*3)+(7*0)+(6*8)+(5*6)+(4*6)+(3*9)+(2*7)+(1*6)=182
182 % 10 = 2
So 1308669-76-2 is a valid CAS Registry Number.
1308669-76-2Relevant articles and documents
ARYL-PYRIDINE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS
-
Page/Page column 56-57, (2011/06/19)
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5 and n are defined herein. The invention also relates to a method for manufacturing compounds of the invention, and their therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
